Bpi Labs Company Profile
What is the competitive landscape for BPI LABS
BPI LABS has ten approved drugs.
There are two tentative approvals on BPI LABS drugs.
Summary for Bpi Labs
| US Patents: | 0 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 10 |
| PTAB Cases with Bpi Labs as petitioner: | See PTAB cases with Bpi Labs as petitioner |
Drugs and US Patents for Bpi Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029-005 | Mar 4, 2024 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029-002 | Feb 4, 2022 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bpi Labs | ABLYSINOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bpi Labs | ABLYSINOL | dehydrated alcohol | SOLUTION;INTRA-ARTERIAL | 207987-001 | Jun 21, 2018 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Bpi Labs | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 209197-001 | May 8, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS | 205029-003 | May 12, 2023 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029-004 | Feb 14, 2024 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
